A Study of a Low-Carbohydrate Diet to Improve Maternal Health After Childbirth (SLIM)

A Randomized Trial of a Low Carbohydrate Diet Versus the Current Recommended Dietary Guidelines to Improve Health Outcomes in Obese Postpartum Women

The study is evaluating the effects of a standard diet to a low carbohydrate diet in obese women after having a baby. The purpose of the study is to determine if a low carbohydrate diet is associated with improvement in insulin sensitivity in postpartum women.

Study Overview

Study Type

Interventional

Enrollment (Actual)

11

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Galveston, Texas, United States, 77555
        • University of Texas Medical Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Delivery at University of Texas Medical Branch
  • Body max index greater than or equal to 30 kilograms/meters squared at the final prenatal visit prior to delivery.
  • Singleton gestation.
  • Accessibility to the internet.
  • Basic understanding and comprehension of the English language to be assessed by study personnel at the time of recruitment.

Exclusion Criteria:

  • Diabetes mellitus on medication.
  • Serious medical condition, such as heart failure, kidney failure, or severe asthma, as determined by the principle investigator.
  • Planned pregnancy during study period.
  • Enrolled in another trial that may affect outcome.
  • Subject unlikely to be followed up after delivery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard of care
Subjects will receive standard counseling on obesity as part of routine postpartum care.
Active Comparator: Low carbohydrate diet education
Subjects will receive educational materials regarding a low carbohydrate diet in addition to the standard counseling on obesity as part of routine postpartum care.
A 200 page informational document that connects with an online application will be provided to subjects.
Active Comparator: Low carbohydrate diet education with behavioral component
Subjects will receive in person instruction regarding a low carbohydrate diet as part of a 12 week course, in addition to receiving educational materials regarding a low carbohydrate diet and the standard counseling on obesity as part of routine postpartum care.
A 200 page informational document that connects with an online application will be provided to subjects.
A 12 week course taught be a certified instructor will teach subjects about a low carbohydrate document. Subjects will also be given a 200 page informational document that connects with an online application.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.
Time Frame: Baseline, 3 months
Homeostatic model assessment for measurement of insulin sensitivity will be computed with fasting insulin and glucose levels (fasting for at least 8 hours) with the following calculation: (glucose x insulin/22.5). This calculation is measured in molar units (mmol/L).
Baseline, 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in insulin sensitivity as measured by homeostatic model assessment of insulin sensitivity.
Time Frame: Baseline, 6 months
Homeostatic model assessment for measurement of insulin sensitivity will be computed with fasting insulin and glucose levels (fasting for at least 8 hours) with the following calculation: (glucose x insulin/22.5). This calculation is measured in molar units (mmol/L).
Baseline, 6 months
Change in weight measured in pounds.
Time Frame: Baseline, 3 months
The subject will be weighed at baseline and at 3 months.The weight will be calculated in pounds.
Baseline, 3 months
Change in weight measured in pounds.
Time Frame: Baseline, 6 months
The subject will be weighed at baseline and at 6 months. The weight will be calculated in pounds.
Baseline, 6 months
Development of diabetes postpartum as measured by 2 hour glucose tolerance test.
Time Frame: 3 months
As part of routine postpartum care, women at risk for diabetes have a glucose tolerance test performed within 3 months postpartum.
3 months
Change in blood pressure as measured by blood pressure cuff in mmHg.
Time Frame: Baseline, 3 months
The subject will have blood pressure checked at baseline and at 3 months. Blood pressure will be calculated in mmHg.
Baseline, 3 months
Change in blood pressure as measured by blood pressure cuff in mmHg.
Time Frame: Baseline, 6 months
The subject will have blood pressure checked at baseline and at 6 months. Blood pressure will be calculated in mmHg.
Baseline, 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sara O Jacobs, MD, University of Texas
  • Principal Investigator: Antonio Saad, MD, University of Texas
  • Study Director: Ashley Salazar, WHNP, University of Texas

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2019

Primary Completion (Actual)

July 1, 2022

Study Completion (Actual)

July 1, 2022

Study Registration Dates

First Submitted

August 1, 2019

First Submitted That Met QC Criteria

August 1, 2019

First Posted (Actual)

August 5, 2019

Study Record Updates

Last Update Posted (Actual)

April 18, 2023

Last Update Submitted That Met QC Criteria

April 14, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Low carbohydrate diet education

3
Subscribe